Abstract
A bitter, astringent taste is often a serious problem, particularly in the case of pediatric drug formulations. The taste of some bitter drugs can be improved by CD complexation. The total elimination of the bitterness has been reported in some cases.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Szejtli J. in: Inclusion Compounds, Vol. 3: Physical Properties and Applications (Eds.: Atwood J. L., Davies J. E. D. and MacNicol D. D.), Academic Press, London, p. 343 (1984).
Andersen, F. M., Bundgaard H. and Mengel H. B.: Int. J. Pharm. 21, 51 (1984).
Fujioka K., Kurosaki Y., Sato S., Noguchi T., Noguchi T. and Yamahira Y.: Chem. Pharm. Bull. 31, 2416 (1983).
Uekama K., Oh K., Otagiri M., Seo H. and Tsuruoka M.: Acta Pharm. Hely. 58, 338 (1983).
Takahashi Y., Tsukuda T., Izumi C., Ikemoto K., Kokubun K., Yagi N. and Takada M.: Chem. Pharm. Bull. 36, 2708 (1988).
Hibi T., Tatsumi M., Hanabusa M., Higuchi R., Imai T. and Otagiri M.: J. Pharm. Soc. Jpn. 104, 990 (1984).
Kim C. K. and Choi H. G.: Yakhak Hoechi 31, 42 (1987) (CA. 107: 64827 ).
Weiszfeiler V. and Szejtli J.: Proceedings of the Fourth International Symposium on Cyclodextrins (Eds.: Huber O. and Szejtli J.), Kluwer Academic Publishers, Dordrecht-Boston-London, p. 359 (1988).
Iwayama Y. and Fujeda S.: Jpn. Kokai 62 185, 011 (1987) (C.A. 108: 101363).
Szente L., Harangi J. and Szejtli J.: Proceedings of the Fourth International Symposium on Cyclodextrins (Eds.: Huber O. and Szejtli J.), Kluwer Academic Publishers, Dordrecht-BostonLondon, p. 545 (1988).
Szejtli J.: Stärke 29, 26 (1977).
Thoß M.: Dissertation, Freie Universität Berlin (1990).
Szejtli J.: Stärke 34, 379 (1982).
Stadler-Szöke A. and Szejtli J.: Acta Pharm. Hung. 49 30 (1979) (C.A. 90: 157039).
Akiyama Y.: Jpn. Kokai 77 114, 014 (1977) (C.A. 88: 27824).
Uekama K., Oh K., Irie T., Otagiri M., Nishimiya Y. and Nara T.: Int. J. Pharm. 25, 339 (1985).
Frömming K.-H., Sandmann R. and Weyermann I.: Dtsch. Apoth. Ztg. 112, 707 (1972).
Kurihara M., Hirayama F., Uekama K. and Yamasaki M.: J. Incl. Phenom. 8, 363 (1990).
Vikmon M., Stadler-Szöke A., Hortobägyi G. and Szejtli J.: Acta Pharm. Technol. 32, 29 (1986).
Szente L., Harangi J. and Szejtli J.: Proceedings of the Fourth International Symposium on Cyclodextrins (Eds.: Huber O. and Szejtli J.), Kluwer Academic Publishers, Dordrecht-BostonLondon, p. 545 (1988).
Akiyama Y.: Jpn. Kokai 78, 126, 089 (1978) (C.A. 90: 92440).
Vinciere F. F., Mulinacci N., Mazzi G., Coran S. A. and Bambagiotti-Alberti, M.: Int. J. Pharm. 48, 119 (1988).
Szejtli J., Bolla-Pusztai E. and Kajtär M.: Pharmazie 37, 725 (1982).
Räcz I., Plachy J., Szabó-Täbori M., Stadler-Szöke A., Vikmon M. and Szejtli J.: Acta Pharm. Hung. 54, 154 (1984) (C.A. 101: 177453).
Pankaj B. Gala P. and Shangraw R.: Abstract Meeting Amer. Pharm. Assoc. PT 1604 (1988).
Nakai Y., Yamamoto K., Terada K. and Kajiyama A.: Chem. Pharm. Bull. 33, 5110 (1985).
Giordano F., Gazzaniga A., Bettinetti G. P. and La Manna A.: Int. J. Pharm. 62, 153 (1990).
Nozawa Y. and Yamamoto A.: Pharm. Acta Helm 64, 24 (1989).
Hüttenrauch R., Fricke S. and Zielke P.: Pharmazie 39, 710 (1984).
Hüttenrauch R. and Benesch I.: Pharmazie 39, 578 (1984).
Shangraw R. F., Pande G. and Gala P.: Minutes Fifth International Symposium on Cyclodextrins (Ed.: Duchêne D.), Editions de Santé, Paris, p. 547 (1990).
Lin S.-Y. and Kao Y.-H.: Int. J. Pharm. 56, 249 (1989).
Szabo-Révész P., Pintye-Hódi K., Miseta M. and Selmeczi B.: Pharm. Ind. 51, 94 (1989).
Pankaj B. Gala P. and Shangraw R.: Abstract Meeting Amer. Pharm. Assoc. PT 1700 (1988).
ElShaboury M. H.: Int. J. Pharm. 63, 95 (1990).
Fenyvesi E., Antal B., Zsadon B. and Szejtli J.: Pharmazie 39, 473 (1984).
Fenyvesi E., Takayama K., Szejtli J. and Nagai T.: Chem. Pharm. Bull. 32, 670 (1984).
Tarimci N. and Celebi N.: Pharmazie 43, 323 (1988).
Lin S.-Y., Kao Y.-H. and Yang J.-C.: Drug Dey. Ind. Pharm. 14, 99 (1988).
Stein M., Schwabe L. and Frömming K.-H.: Pharm. Ind. 53, 186 (1991).
Nakai Y., Yamamoto K., Terada K. and Sakai M.: Chem. Pharm. Bull. 36, 4554 (1988).
Oguchi T., Terada K., Yamamoto K. and Nakai Y.: Chem. Pharm. Bull. 37, 1886 (1989).
Szejtli J. in: Inclusion Compounds,Vol. 3: Physical Properties and Applications (Eds.: Atwood J. L., Davies J. E. D. and MacNicol D. D.) Academic Press, London, p. 351 (1984).
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Frömming, KH., Szejtli, J. (1994). Pharmaceutical-Technological Aspects of Cyclodextrins in Drug Formulation. In: Cyclodextrins in Pharmacy. Topics in Inclusion Science, vol 5. Springer, Dordrecht. https://doi.org/10.1007/978-94-015-8277-3_7
Download citation
DOI: https://doi.org/10.1007/978-94-015-8277-3_7
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-4242-2
Online ISBN: 978-94-015-8277-3
eBook Packages: Springer Book Archive